Philip Walden Loberg Jr., EVP, Interim CFO at Valeant Pharmaceuticals International, Inc. (VRX), bought 7,500 shares at $52.82 ($396K) on 2011-06-09, disclosed to the SEC on 2011-06-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.